Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines

Wen Chi L. Chang, Terry V. Zenser, Harry S. Cooper, Margie L. Clapper

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Individuals with ulcerative colitis face an increased risk of developing colorectal cancer and would benefit from early chemopreventive intervention. Results from preclinical studies in the mouse model of dextran sulfate sodium-induced colitis demonstrate that flat and polypoid colitis-associated dysplasias arise via distinct genetic pathways, impacted by the allelic status of p53. Furthermore, flat and polypoid dysplasias vary in their response to induction by the heterocyclic amine 2-amino-3-methylimidazo[4,5- f]quinoline (IQ) and inhibition by 5-aminosalicylic acid, a common therapy for the maintenance of colitis patients. These data suggest that use of combination therapy is essential for the optimal inhibition of colitis-associated colorectal cancer.

Original languageEnglish
Pages (from-to)62-68
Number of pages7
JournalCancer Letters
Volume334
Issue number1
DOIs
StatePublished - Jun 28 2013

Keywords

  • Amines/toxicity
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal/pharmacology
  • Apoptosis/drug effects
  • Carcinogens/toxicity
  • Cell Proliferation/drug effects
  • Colitis, Ulcerative/complications
  • Colitis/chemically induced
  • Colorectal Neoplasms/drug therapy
  • Dextran Sulfate/toxicity
  • Disease Models, Animal
  • Humans
  • Meat Products
  • Mesalamine/pharmacology
  • Mice
  • Nitric Oxide Synthase Type II/antagonists & inhibitors
  • Quinolines/toxicity

Fingerprint

Dive into the research topics of 'Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines'. Together they form a unique fingerprint.

Cite this